Literature DB >> 15784178

Understanding breast cancer risk -- where do we stand in 2005?

R G Dumitrescu1, I Cotarla.   

Abstract

Breast cancer is the most frequent cancer in women and represents the second leading cause of cancer death among women (after lung cancer). The etiology of breast cancer is still poorly understood with known breast cancer risk factors explaining only a small proportion of cases. Risk factors that modulate the development of breast cancer discussed in this review include: age, geographic location (country of origin) and socioeconomic status, reproductive events, exogenous hormones, lifestyle risk factors (alcohol, diet, obesity and physical activity), familial history of breast cancer, mammographic density, history of benign breast disease, ionizing radiation, bone density, height, IGF- 1 and prolactin levels, chemopreventive agents. Additionally, we summarized breast cancer risk associated with the following genetic factors: breast cancer susceptibility high-penetrance genes (BRCA1, BRCA2, p53, PTEN, ATM, NBS1 or LKB1) and low-penetrance genes such as cytochrome P450 genes (CYP1A1, CYP2D6, CYP19), glutathione S-transferase family (GSTM1, GSTP1), alcohol and one-carbon metabolism genes (ADH1C and MTHFR), DNA repair genes (XRCC1, XRCC3, ERCC4/XPF) and genes encoding cell signaling molecules (PR, ER, TNFalpha or HSP70). All these factors contribute to a better understanding of breast cancer risk. Nonetheless, in order to evaluate more accurately the overall risk of breast tumorigenesis, novel genetic and phenotypic traits need to be identified.

Entities:  

Mesh:

Year:  2005        PMID: 15784178      PMCID: PMC6741339          DOI: 10.1111/j.1582-4934.2005.tb00350.x

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


  107 in total

Review 1.  Tumor suppressor genes in breast cancer.

Authors:  S Oesterreich; S A Fuqua
Journal:  Endocr Relat Cancer       Date:  1999-09       Impact factor: 5.678

2.  Global cancer statistics.

Authors:  D M Parkin; P Pisani; J Ferlay
Journal:  CA Cancer J Clin       Date:  1999 Jan-Feb       Impact factor: 508.702

Review 3.  Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: emerging evidence for their role as risk modifiers.

Authors:  H Bartsch; J Nair; R W Owen
Journal:  Carcinogenesis       Date:  1999-12       Impact factor: 4.944

4.  Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women.

Authors:  S E Hankinson; W C Willett; D S Michaud; J E Manson; G A Colditz; C Longcope; B Rosner; F E Speizer
Journal:  J Natl Cancer Inst       Date:  1999-04-07       Impact factor: 13.506

5.  The risk of breast cancer following reproductive surgery.

Authors:  N Kreiger; M Sloan; M Cotterchio; V Kirsh
Journal:  Eur J Cancer       Date:  1999-01       Impact factor: 9.162

6.  Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.

Authors: 
Journal:  Lancet       Date:  1997-10-11       Impact factor: 79.321

7.  Alcohol dehydrogenase 3 genotype modification of the association of alcohol consumption with breast cancer risk.

Authors:  J L Freudenheim; C B Ambrosone; K B Moysich; J E Vena; S Graham; J R Marshall; P Muti; R Laughlin; T Nemoto; L C Harty; G A Crits; A W Chan; P G Shields
Journal:  Cancer Causes Control       Date:  1999-10       Impact factor: 2.506

8.  Adolescence and breast carcinoma risk.

Authors:  C S Berkey; A L Frazier; J D Gardner; G A Colditz
Journal:  Cancer       Date:  1999-06-01       Impact factor: 6.860

Review 9.  The glutathione S-transferases: influence of polymorphism on cancer susceptibility.

Authors:  R C Strange; A A Fryer
Journal:  IARC Sci Publ       Date:  1999

10.  Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy.

Authors:  C Magnusson; J A Baron; N Correia; R Bergström; H O Adami; I Persson
Journal:  Int J Cancer       Date:  1999-05-05       Impact factor: 7.396

View more
  111 in total

1.  Mesenchymal stem cells in mammary adipose tissue stimulate progression of breast cancer resembling the basal-type.

Authors:  Min Zhao; Patrick C Sachs; Xu Wang; Catherine I Dumur; Michael O Idowu; Valentina Robila; Michael P Francis; Joy Ware; Matthew Beckman; Aylin Rizki; Shawn E Holt; Lynne W Elmore
Journal:  Cancer Biol Ther       Date:  2012-06-06       Impact factor: 4.742

2.  Breast cancer knowledge and early detection among Hispanic women with a family history of breast cancer along the U.S.-Mexico border.

Authors:  Yelena Bird; John Moraros; Matthew P Banegas; Sasha King; Surasri Prapasiri; Beti Thompson
Journal:  J Health Care Poor Underserved       Date:  2010-05

3.  Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma.

Authors:  Jintao Zhang; Kaijuan Wang; Jianzhong Zhang; Samuel S Liu; Liping Dai; Jian-Ying Zhang
Journal:  J Proteome Res       Date:  2011-05-03       Impact factor: 4.466

4.  Associations of polymorphisms of folate cycle enzymes and risk of breast cancer in a Brazilian population are age dependent.

Authors:  Rita de Cássia Carvalho Barbosa; Débora Costa Menezes; Thiago Fernando Vasconcelos Freire; Diogo Campos Sales; Victor Hugo Medeiros Alencar; Silvia Helena Barem Rabenhorst
Journal:  Mol Biol Rep       Date:  2011-12-02       Impact factor: 2.316

5.  BRCA1/BRCA2 gene mutations/SNPs and BRCA1 haplotypes in early-onset breast cancer patients of Indian ethnicity.

Authors:  Abida Juwle; Dhananjaya Saranath
Journal:  Med Oncol       Date:  2012-07-03       Impact factor: 3.064

6.  Mediation analysis of the alcohol-postmenopausal breast cancer relationship by sex hormones in the EPIC cohort.

Authors:  Nada Assi; Sabina Rinaldi; Vivian Viallon; S Ghazaleh Dashti; Laure Dossus; Agnès Fournier; Iris Cervenka; Marina Kvaskoff; Renée Turzanski-Fortner; Manuela Bergmann; Heiner Boeing; Salvatore Panico; Fulvio Ricceri; Domenico Palli; Rosario Tumino; Sara Grioni; María José Sánchez Pérez; María-Dolores Chirlaque; Catalina Bonet; Aurelio Barricarte Gurrea; Pilar Amiano Etxezarreta; Susana Merino; H Bas Bueno de Mesquita; Carla H van Gils; Charlotte Onland-Moret; Anne Tjønneland; Kim Overvad; Antonia Trichopoulou; Georgia Martimianaki; Anna Karakatsani; Tim Key; Sofia Christakoudi; Merete Ellingjord-Dale; Kostas Tsilidis; Elio Riboli; Rudolf Kaaks; Marc J Gunter; Pietro Ferrari
Journal:  Int J Cancer       Date:  2019-04-30       Impact factor: 7.396

7.  Effects of prior oral contraceptive use and soy isoflavonoids on estrogen-metabolizing cytochrome P450 enzymes.

Authors:  L M Scott; P Durant; S Leone-Kabler; C E Wood; T C Register; A Townsend; J M Cline
Journal:  J Steroid Biochem Mol Biol       Date:  2008-10-08       Impact factor: 4.292

8.  Collagen density regulates xenobiotic and hypoxic response of mammary epithelial cells.

Authors:  Colleen S Curran; Esteban R Carrillo; Suzanne M Ponik; Patricia J Keely
Journal:  Environ Toxicol Pharmacol       Date:  2014-11-01       Impact factor: 4.860

9.  Serum factors and clinical characteristics associated with serum E-screen activity.

Authors:  Jue Wang; Amy Trentham-Dietz; Jocelyn D C Hemming; Curtis J Hedman; Brian L Sprague
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-04-15       Impact factor: 4.254

10.  Migraine in postmenopausal women and the risk of invasive breast cancer.

Authors:  Robert W Mathes; Kathleen E Malone; Janet R Daling; Scott Davis; Sylvia M Lucas; Peggy L Porter; Christopher I Li
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.